2.75
+0.12(+4.56%)
Currency In USD
| Previous Close | 2.63 |
| Open | 2.65 |
| Day High | 2.75 |
| Day Low | 2.57 |
| 52-Week High | 6.01 |
| 52-Week Low | 1.1 |
| Volume | 172,993 |
| Average Volume | 310,856 |
| Market Cap | 54.07M |
| PE | -1.24 |
| EPS | -2.21 |
| Moving Average 50 Days | 2.86 |
| Moving Average 200 Days | 2.5 |
| Change | 0.12 |
If you invested $1000 in NRx Pharmaceuticals, Inc. (NRXP) since IPO date, it would be worth $28.65 as of September 08, 2025 at a share price of $2.75. Whereas If you bought $1000 worth of NRx Pharmaceuticals, Inc. (NRXP) shares 5 years ago, it would be worth $25.53 as of September 08, 2025 at a share price of $2.75.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th
GlobeNewswire Inc.
Sep 03, 2025 12:03 PM GMT
WILMINGTON, Del., Sept. 03, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"), an interve
UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office
GlobeNewswire Inc.
Sep 02, 2025 5:19 PM GMT
NRx CEO presented plans for HOPE Therapeutics rollout in September 2025 and establishment of flagship location in Palm Beach, FL during symposium presentation with leadership from Rockefeller Capital and Matthew Rockefeller.Company has recently raise
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital
GlobeNewswire Inc.
Sep 02, 2025 12:41 PM GMT
NRx CEO presented plans for HOPE Therapeutics rollout in September 2025 and establishment of flagship location in Palm Beach, FL during symposium presentation with leadership from Rockefeller Capital and Matthew Rockefeller.Company has recently raise